Admin and corporate - from 395,000 Q1 to 566,000 Q2. (Q3 est. 500,000)
R & D - from 318,000 Q1 to 653,000 Q2. (Q3 est. 750,000)
Seems strange they have declared no product manufacturing and operating costs or advertising and marketing costs, for the year so far.
Just a couple of notes from the mini up date.-
- Many aspects of this lengthy review have now been successfully closed out.
- Following a successful meeting in November the Company now anticipates a CE Mark determination in the next few weeks. (Those dates I posted a few days ago may be right)
- And of course, Me Kenny is " delighted ".
OLI
- Forums
- ASX - By Stock
- Ann: Appendix 4C - Quarterly Cash Flow
OSL
oncosil medical ltd
Add to My Watchlist
20.6%
!
$1.23

Admin and corporate - from 395,000 Q1 to 566,000 Q2. (Q3 est....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.23 |
Change
0.210(20.6%) |
Mkt cap ! $17.49M |
Open | High | Low | Value | Volume |
$1.05 | $1.24 | $1.03 | $200.2K | 169.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 1.190 |
1 | 90 | 1.160 |
1 | 325 | 1.130 |
1 | 5000 | 1.120 |
1 | 7500 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 60000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online